Rankings
▼
Calendar
RAPT Q1 2022 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$641,000
-47.5% YoY
Gross Profit
$641,000
100.0% margin
Operating Income
-$21M
-3241.3% margin
Net Income
-$20M
-3193.1% margin
EPS (Diluted)
$-5.54
QoQ Revenue Growth
-15.2%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$188M
Total Liabilities
$20M
Stockholders' Equity
$168M
Cash & Equivalents
$32M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$641,000
$1M
-47.5%
Gross Profit
$641,000
$1M
-47.5%
Operating Income
-$21M
-$17M
-25.5%
Net Income
-$20M
-$17M
-23.9%
← FY 2022
All Quarters
Q2 2022 →